A2. Use of alternative performance measures
Guidelines concerning non-IFRS performance measures for companies with securities listed on a regulated market in the EU have been issued by the ESMA (The European Securities and Markets Authority). These guidelines are to be applied to alternative performance measures not supported under IFRS.
The Annual and Sustainability Report refers to a number of performance measures not defined in IFRS. These performance measures are used to assist investors and company management to analyze the company’s operations and objectives. As these non-IFRS measures may differ from similar terms used by other companies, descriptions of the various measures used as a compliment to the financial information required according to IFRS are presented below.
Return measures |
Return is a financial term that describes how much the value of an asset changes from an earlier point in time |
|
---|---|---|
Non-IFRS performance measure |
Description |
Reason for use of the measure |
Return on capital employed, ROCE |
Accumulated return on capital employed is calculated as 12-months rolling operating profit before amortization of acquisition-related intangible assets (EBITA) as a percentage of an average of capital employed during the five most recent quarters. The corresponding key figure for a single quarter is calculated as EBITA for the quarter multiplied by four as a percentage of capital employed for the two most recent quarters. |
A central ratio for measuring return on capital tied up in operations. |
Adjusted return on capital employed, ROCE |
Accumulated return on capital employed is calculated as 12-months rolling operating profit before amortization of acquisition-related intangible assets (EBITA), excluding items affecting comparability, as a percentage of an average of capital employed during the five most recent quarters. The corresponding key figure for a single quarter is calculated as EBITA for the quarter, excluding items affecting comparability, multiplied by four as a percentage of capital employed for the two most recent quarters. |
A central ratio for measuring return on capital tied up in operations, excluding items affecting comparability. |
SEKm |
2021 |
2020 |
2019 |
---|---|---|---|
ADJUSTED RETURN ON CAPITAL EMPLOYED, ROCE |
|
|
|
EBITA |
14,051 |
17,567 |
15,127 |
Items affecting comparability |
–371 |
59 |
713 |
Adjusted EBITA |
13,680 |
17,626 |
15,840 |
Average capital employed |
114,163 |
112,473 |
114,663 |
Adjusted return on capital employed, ROCE |
12.0% |
15.7% |
13.8% |
Capital measures |
Shows how capital is utilized and the company’s financial strength |
|
---|---|---|
Non-IFRS performance measure |
Description |
Reason for use of the measure |
Return on equity |
For the Group, return on equity is calculated as profit for the period as a percentage of average equity. |
Shows, from a shareholder perspective, the return that is generated on the owners’ capital that is invested in the company. |
Adjusted return on equity |
For the Group, adjusted return on equity is calculated as profit for the period, excluding items affecting comparability, as a percentage of average equity. |
Shows, from a shareholder perspective, the return excluding items affecting comparability that is generated on the owners’ capital that is invested in the company. |
Equity |
The equity reported in the consolidated balance sheet consists of taxed equity increased by the equity portion of the Group’s untaxed reserves and non-controlling interests. The deferred tax liability in untaxed reserves has been calculated on the basis of the corporate tax rate decided to apply when the reserves are expected to be realized. |
Equity is the difference between the Group’s assets and liabilities, which corresponds to the Group’s equity contributed by owners and the Group’s accumulated profits including the share of associated non-controlling interests. |
Equity per share |
Equity in relation to the average number of shares outstanding that exist in Essity Aktiebolag (publ). |
A measure of the amount of equity that exists per outstanding share and is used for measuring the share against the share price. |
Equity/assets ratio |
Equity expressed as a percentage of total assets. |
A traditional measure for showing financial risk, expressing the percentage of total assets that is financed by the owners. |
Capital employed |
The Group’s and business areas’ capital employed is calculated as the balance sheet’s total assets, excluding interest-bearing assets and pension assets, less total liabilities, excluding interest-bearing liabilities and pension liabilities. |
This measure shows the amount of total capital that is used in the operations and is thus one of the components for measuring the return from operations. |
SEKm |
2021 |
2020 |
2019 |
---|---|---|---|
CAPITAL EMPLOYED |
|
|
|
Total assets |
175,050 |
154,645 |
162,295 |
Financial assets |
–6,905 |
–9,530 |
–6,988 |
Non-current, non-interest-bearing liabilities |
–8,056 |
–6,700 |
–7,269 |
Current, non-interest-bearing liabilities |
–36,149 |
–32,385 |
–34,297 |
Capital employed |
123,940 |
106,030 |
113,741 |
|
|
|
|
CAPITAL EMPLOYED |
|
|
|
Personal Care |
47,085 |
40,505 |
44,268 |
Consumer Tissue |
51,255 |
45,283 |
47,345 |
Professional Hygiene |
24,518 |
20,915 |
22,996 |
Other |
1,082 |
–673 |
–868 |
Capital employed |
123,940 |
106,030 |
113,741 |
Non-IFRS performance measure |
Description |
Reason for use of the measure |
---|---|---|
Capital turnover |
Net sales for the year divided by average capital employed. |
Shows in a clear manner how effectively capital is employed. Together with sales growth and the operating margin, the capital turnover ratio is a key measure for monitoring value creation. |
Working capital |
The Group’s and business areas’ working capital is calculated as current operating receivables less current operating liabilities. |
This measure shows how much working capital is tied up in the operations and can be put in relation to net sales to understand how effectively tied-up working capital is used. |
SEKm |
2021 |
2020 |
2019 |
---|---|---|---|
WORKING CAPITAL |
|
|
|
Inventories |
19,339 |
16,383 |
15,764 |
Trade receivables |
19,871 |
17,825 |
19,864 |
Other current receivables |
5,787 |
2,173 |
2,113 |
Trade payables |
–18,030 |
–14,791 |
–15,802 |
Other current liabilities |
–15,807 |
–14,545 |
–14,998 |
Other |
–3 |
101 |
–159 |
Working capital |
11,157 |
7,146 |
6,782 |
Non-IFRS performance measure |
Description |
Reason for use of the measure |
---|---|---|
Net debt |
The sum of consolidated interest-bearing liabilities, including pension liabilities and accrued interest less pension assets, cash and cash equivalents and interest-bearing current and non-current receivables. |
Net debt is the most relevant measure for showing the company’s total debt financing. |
SEKm |
2021 |
2020 |
2019 |
---|---|---|---|
NET DEBT |
|
|
|
Surplus in funded pension plans |
1,439 |
2,817 |
2,841 |
Non-current financial assets |
412 |
738 |
694 |
Current financial assets |
1,150 |
993 |
525 |
Cash and cash equivalents |
3,904 |
4,982 |
2,928 |
Financial assets |
6,905 |
9,530 |
6,988 |
Non-current financial liabilities |
47,443 |
38,202 |
43,079 |
Provisions for pensions |
4,149 |
5,328 |
5,866 |
Current financial liabilities |
10,746 |
8,688 |
8,983 |
Financial liabilities |
62,338 |
52,218 |
57,928 |
Net debt |
55,433 |
42,688 |
50,940 |
Non-IFRS performance measure |
Description |
Reason for use of the measure |
---|---|---|
Debt/equity ratio |
Debt/equity ratio is expressed as net debt in relation to equity. |
Shows financial risk and is the most useful measure for management to monitor the level of the company’s indebtedness. |
Debt payment capacity, % |
Debt payment capacity is expressed as 12 months rolling cash earnings (see Cash flow performance measures) in relation to closing net debt. |
A financial measure that shows the company’s capacity to repay its debt. |
Adjusted debt payment capacity, % |
Adjusted debt payment capacity expressed as 12 months rolling adjusted cash earnings (see Cash flow performance measures) in relation to closing net debt. |
A financial measure that shows the company’s capacity to repay its debt, adjusted for the impact of items affecting comparability. |
Net debt/EBITDA |
Calculated as the closing balance of net debt in relation to 12 months rolling EBITDA. |
A financial measure that shows the company’s capacity to repay its debt. |
Net debt/Adjusted EBITDA |
Calculated as the closing balance of net debt in relation to 12 months rolling EBITDA, excluding items affecting comparability. |
A financial measure that shows the company’s capacity to repay its debt, adjusted for the impact of items affecting comparability. |
Interest coverage ratio |
Calculated on a net basis, according to which operating profit is divided by financial items. |
Helps to show the company’s capacity to cover its interest expenses. |
SEKm |
2021 |
2020 |
2019 |
---|---|---|---|
Debt/equity ratio, multiple |
0.81 |
0.67 |
0.81 |
Debt payment capacity, % |
29 |
46 |
38 |
Adjusted debt payment capacity, % |
45 |
45 |
40 |
Net debt/EBITDA |
2.69 |
1.75 |
2.33 |
Net debt/Adjusted EBITDA |
2.77 |
1.76 |
2.25 |
Performance measures |
Various types of performance measures and margin measures expressed as a percentage of sales |
|
---|---|---|
Non-IFRS performance measure |
Description |
Reason for use of the measure |
Organic sales growth |
Underlying change in sales growth compared with the preceding period attributable to changed volume, price or product mix and excluding changes attributable to exchange rate effects, acquisitions and divestments. |
This measure is of major importance for management in its monitoring of underlying organic sales growth driven by changes in volume, price and product mix for comparable units between different periods. |
Sales growth including organic sales growth and acquisitions |
Sales growth that includes organic sales growth and acquisitions. |
This measure shows how the company grows organically and through acquisitions. |
SEKm |
2021 |
2020 |
2019 |
||
---|---|---|---|---|---|
SALES GROWTH |
|
|
|
||
Personal Care |
|
|
|
||
Organic sales growth |
2,308 |
–19 |
1,549 |
||
Acquisitions |
626 |
165 |
37 |
||
Sales growth including organic sales growth and acquisitions |
2,934 |
146 |
1,586 |
||
Divestments |
–451 |
–143 |
–212 |
||
Exchange rate effects1) |
–1,939 |
–2,248 |
1,623 |
||
Recognized change |
544 |
–2,245 |
2,997 |
||
|
|
|
|
||
Consumer Tissue |
|
|
|
||
Organic sales growth |
232 |
2,060 |
2,754 |
||
Acquisitions |
380 |
– |
53 |
||
Sales growth including organic sales growth and acquisitions |
612 |
2,060 |
2,807 |
||
Divestments |
–494 |
– |
– |
||
Exchange rate effects1) |
–1,253 |
–1,743 |
1,972 |
||
Recognized change |
–1,135 |
317 |
4,779 |
||
|
|
|
|
||
Professional Hygiene |
|
|
|
||
Organic sales growth |
1,443 |
–4,501 |
1,010 |
||
Acquisitions |
452 |
– |
1 |
||
Sales growth including organic sales growth and acquisitions |
1,895 |
–4,501 |
1,011 |
||
Divestments |
–19 |
– |
– |
||
Exchange rate effects1) |
–1,151 |
–812 |
1,703 |
||
Recognized change |
725 |
–5,313 |
2,714 |
||
|
|
|
|
||
Group |
|
|
|
||
Organic sales growth |
3,962 |
–2,439 |
5,297 |
||
Acquisitions |
1,458 |
165 |
91 |
||
Sales growth including organic sales growth and acquisitions |
5,420 |
–2,274 |
5,388 |
||
Divestments |
–964 |
–143 |
–212 |
||
Exchange rate effects1) |
–4,342 |
–4,806 |
5,299 |
||
Recognized change |
114 |
–7,223 |
10,475 |
||
|
|
|
|
||
ORGANIC SALES GROWTH % |
|
|
|
||
Previous period sales |
121,752 |
128,975 |
118,500 |
||
Organic sales growth |
3,962 |
–2,439 |
5,297 |
||
Organic sales growth % |
3.3% |
–1.9% |
4.5% |
||
|
|
|
|
||
SALES GROWTH % |
|
|
|
||
Previous period sales |
121,752 |
128,975 |
118,500 |
||
Sales growth including organic sales growth and acquisitions |
5,420 |
–2,274 |
5,388 |
||
Sales growth including organic sales growth and acquisitions % |
4.5% |
–1.8% |
4.5% |
||
|
Non-IFRS performance measure |
Description |
Reason for use of the measure |
---|---|---|
Adjusted gross profit |
Net sales minus cost of goods sold excluding items affecting comparability. |
Gross profit shows the company’s earnings before the effects of sales, general and administration. Adjusted gross profit excludes items affecting comparability. |
Operating profit before depreciation, amortization and impairment of property, plant and equipment and intangible assets (EBITDA) |
Calculated as operating profit before depreciation, amortization and impairment of property, plant and equipment and intangible assets. |
This measure is a complement to operating profit, as it shows the cash earnings from operations. |
Adjusted operating profit before depreciation, amortization and impairment of property, plant and equipment and intangible assets (EBITDA) |
Calculated as operating profit before depreciation, amortization and impairment of property, plant and equipment and intangible assets excluding items affecting comparability. |
This measure is a complement to operating profit, as it shows the cash earnings from operations adjusted for the impact of items affecting comparability. |
Operating profit before amortization of acquisition-related intangible assets (EBITA) |
Calculated as operating profit after depreciation, amortization and impairment of property, plant and equipment and intangible assets but before amortization and impairment of acquisition-related intangible assets. |
The measure is a good complement to enable earnings comparisons with other companies, regardless of whether business activities are based on acquisitions or organic growth. |
Adjusted operating profit before amortization of acquisition-related intangible assets (EBITA) |
Calculated as operating profit after depreciation, amortization and impairment of property, plant and equipment and intangible assets but before amortization and impairment of acquisition-related intangible assets, excluding items affecting comparability. |
The measure is a good complement to enable earnings comparisons with other companies, regardless of whether business activities were based on acquisitions or organic growth, and is also adjusted for the impact of items affecting comparability. |
SEKm |
2021 |
2020 |
2019 |
---|---|---|---|
Operating profit before depreciation, amortization and impairment of property, plant and equipment and intangible assets (EBITDA) |
|
|
|
Operating profit |
13,199 |
16,758 |
14,349 |
Amortization of acquisition-related intangible assets |
852 |
809 |
778 |
Depreciation/amortization |
5,424 |
5,618 |
5,815 |
Depreciation right-of-use assets |
938 |
922 |
884 |
Impairment |
–2 |
125 |
79 |
Items affecting comparability, net of impairment |
179 |
197 |
–27 |
EBITDA |
20,590 |
24,429 |
21,878 |
Items affecting comparability excluding depreciation/amortization and impairment |
–550 |
–138 |
740 |
Adjusted operating profit before depreciation, amortization and impairment of property, plant and equipment and intangible assets (EBITDA) |
20,040 |
24,291 |
22,618 |
SEKm |
2021 |
2020 |
2019 |
---|---|---|---|
Adjusted operating profit before amortization of acquisition-related intangible assets (EBITA) |
|
|
|
Operating profit |
13,199 |
16,758 |
14,349 |
Amortization of acquisition-related intangible assets |
852 |
809 |
778 |
Operating profit before amortization of acquisition-related intangible assets (EBITA) |
14,051 |
17,567 |
15,127 |
EBITA margin |
11.5% |
14.4% |
11.7% |
Items affecting comparability, cost of goods sold |
146 |
181 |
243 |
Items affecting comparability, sales, general and administration |
–517 |
–122 |
470 |
Adjusted operating profit before amortization of acquisition-related intangible assets (EBITA) |
13,680 |
17,626 |
15,840 |
Adjusted EBITA margin |
11.2% |
14.5% |
12.3% |
Non-IFRS performance measure |
Description |
Reason for use of the measure |
---|---|---|
Items affecting comparability |
Under items affecting comparability, Essity includes costs in connection with acquisitions, restructuring, impairment and other specific events that are relevant when comparing earnings for one period with those of another. The item other specific events is specified in Note B3 Operating expenses. |
Separate reporting of items affecting comparability between periods provides a better understanding of the company’s underlying operating activities. |
Restructuring costs |
Costs for impairment together with headcount reductions in connection with restructuring. |
This measure shows the specific costs that have arisen in connection with restructuring of a specific operation, which contributes to a better understanding of the underlying cost level in the continuing operations. |
Adjusted gross margin |
Relates to adjusted gross profit as a percentage of net sales for the period. |
Adjusted gross margin is cleared of items affecting comparability and is thus a better measure than gross margin for showing the company’s margins before the effect of costs such as sales, general and administration. |
EBITA margin |
Operating profit before amortization of acquisition-related intangible assets as a percentage of net sales for the period. |
EBITA margin is a good complement to enable operating margin comparisons with other companies, regardless of whether business activities are based on acquisitions or organic growth. |
Adjusted EBITA margin |
Operating profit before amortization of acquisition-related intangible assets, excluding items affecting comparability, as a percentage of net sales for the period. |
Adjusted EBITA margin is a good complement to enable operating margin comparisons excluding items affecting comparability with other companies, regardless of whether business activities are based on acquisitions or organic growth. |
Operating margin |
Operating profit as a percentage of net sales for the period. |
The operating margin is a key measure together with sales growth and capital turnover ratio for monitoring value creation. |
Adjusted operating margin |
Operating profit, excluding items affecting comparability, as a percentage of net sales for the period. |
Adjusted operating margin is a key measure together with sales growth and capital turnover ratio for monitoring value creation. |
Adjusted operating profit |
Calculated as operating profit before financial items and tax, excluding items affecting comparability. |
Adjusted operating profit is a key ratio for control of the units and provides a better understanding of earnings performance of the operations than the non-adjusted operating profit. |
SEKm |
2021 |
2020 |
2019 |
---|---|---|---|
ADJUSTED OPERATING PROFIT |
|
|
|
Operating profit |
13,199 |
16,758 |
14,349 |
Items affecting comparability |
–371 |
59 |
713 |
Adjusted operating profit |
12,828 |
16,817 |
15,062 |
Adjusted operating margin |
10.5% |
13.8% |
11.7% |
Non-IFRS performance measure |
Description |
Reason for use of the measure |
---|---|---|
Financial net margin |
Net financial items divided by net sales. |
This measure shows the relationship between net financial items and net sales. |
Adjusted profit before tax |
Calculated as profit before tax, excluding items affecting comparability. |
This is a useful measure for showing total profit for the company including financing costs, but not affected by taxes and items affecting comparability. |
Adjusted tax |
Tax expenses for the period adjusted for tax expenses relating to items affecting comparability. |
A useful measure to show the total tax expense for the period, adjusted for taxes related to items affecting comparability. |
SEKm |
2021 |
2020 |
2019 |
---|---|---|---|
ADJUSTED TAX |
|
|
|
Tax |
–2,727 |
–4,053 |
–2,828 |
Tax relating to items affecting comparability |
–76 |
–1 |
–159 |
Adjusted tax |
–2,803 |
–4,054 |
–2,987 |
Non-IFRS performance measure |
Description |
Reason for use of the measure |
---|---|---|
Adjusted profit for the period |
Profit for the period excluding items affecting comparability. |
Shows the period’s total underlying earnings capacity excluding items affecting comparability. |
Net margin |
Profit for the period as a percentage of net sales for the year. |
The net margin shows the remaining share of net sales after all of the company’s costs, including income tax, have been deducted. |
Earnings per share |
Profit for the period attributable to owners of the Parent company divided by the number of shares outstanding. |
Earnings per share is a good measure of the company’s profitability and is used to determine the value of a company’s outstanding shares. |
Adjusted earnings per share |
Adjusted earnings for the period attributable to owners of the Parent company, excluding amortization of acquisition-related intangible assets after tax divided by number of shares. |
Adjusted earnings per share is a good measure of the company’s profitability and is used to determine the value of a company’s outstanding shares. The measure is a good complement to enable comparison of earnings per share with other companies, regardless of whether business activities are based on acquisitions or organic growth. |
Cash flow performance measures |
Various performance measures and costs that have impacted the company’s cash flow |
|
---|---|---|
Non-IFRS performance measure |
Description |
Reason for use of the measure |
Cash earnings |
Cash earnings consist of the net of operating profit before depreciation, amortization and impairment of property, plant and equipment and intangible assets (EBITDA), financial income and expenses and income taxes. |
A financial measure used when calculating the company’s debt payment capacity, see Capital measures. |
Adjusted cash earnings |
Adjusted cash earnings consist of the net of adjusted operating profit before depreciation, amortization and impairment of property, plant and equipment and intangible assets (EBITDA), financial income and expenses and income taxes. |
A financial measure used when calculating the company’s debt payment capacity, see Capital measures. |
Operating cash surplus |
Calculated as operating profit with a reversal of depreciation, amortization and impairment of property, plant and equipment and intangible assets. Share of profits of associated companies and joint ventures, items affecting comparability and capital gains/losses are excluded. |
This measure shows the cash flow generated by profit and is part of the follow-up of cash flow. |
Investments in non-current assets, net |
Investments in non-current assets, net, to maintain competitiveness, such as maintenance, rationalization and replacement measures or investments of an environmental nature and strategic investments in sites. |
Shows the size of the capital expenditures required to maintain existing manufacturing capacity and investments in expansion and other growth measures. |
Operating cash flow before investments in operating assets through leases |
Operating cash flow consists of the sum of operating cash surplus and change in working capital, with deductions for net investments in non-current assets and restructuring costs. |
This is an important control measure of operating activities that the units have control over themselves. |
Investments in operating assets through leases |
Additional right-of-use of assets directly attributable to operating activities. Mainly leases for distribution centers. |
Investments in operating assets through leases is part of the follow-up of cash flow that the units have control over themselves. |
Operating cash flow |
Consists of the sum of operating cash surplus and change in working capital, with deductions for net investments in non-current assets and restructuring costs and investments in operating assets through leases. |
This is an important control measure of operating activities that the units have control over themselves. |
Investments in non-operating assets through leases |
Additional right-of-use of assets that are not directly attributable to operating activities, mainly leases for offices. |
Investments through leases in non-operating assets that the units do not have control over themselves. These are recognized in the operating cash flow statement as an explanatory item in changes to net debt. |
SEKm |
2021 |
2020 |
2019 |
---|---|---|---|
OPERATING CASH FLOW |
|
|
|
Personal Care |
|
|
|
Operating cash surplus |
8,882 |
9,089 |
8,785 |
Change in working capital |
–471 |
236 |
401 |
Investments in non-current assets, net |
–1,779 |
–1,658 |
–1,866 |
Restructuring costs, etc. |
–89 |
–101 |
–644 |
Operating cash flow before investments in operating assets through leases |
6,543 |
7,566 |
6,676 |
Investments in operating assets through leases |
–74 |
–81 |
–181 |
Operating cash flow |
6,469 |
7,485 |
6,495 |
|
|
|
|
Consumer Tissue |
|
|
|
Operating cash surplus |
7,379 |
10,817 |
8,107 |
Change in working capital |
403 |
–548 |
–553 |
Investments in non-current assets, net |
–3,563 |
–3,191 |
–2,239 |
Restructuring costs, etc. |
–281 |
–418 |
–251 |
Operating cash flow before investments in operating assets through leases |
3,938 |
6,660 |
5,064 |
Investments in operating assets through leases |
–247 |
–205 |
–194 |
Operating cash flow |
3,691 |
6,455 |
4,870 |
|
|
|
|
Professional Hygiene |
|
|
|
Operating cash surplus |
4,782 |
5,479 |
6,589 |
Change in working capital |
–705 |
–360 |
438 |
Investments in non-current assets, net |
–941 |
–1,135 |
–1,402 |
Restructuring costs, etc. |
–466 |
–677 |
–603 |
Operating cash flow before investments in operating assets through leases |
2,670 |
3,307 |
5,022 |
Investments in operating assets through leases |
–158 |
–124 |
–84 |
Operating cash flow |
2,512 |
3,183 |
4,938 |